longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SBCWW

SBCWW
0.31500.00%( 0.0000 )

LongbridgeAI

SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 43.35 M

Earnings Watch
Nov 14, 2025 at 12:04 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Revenue: As of FY2025 Q3, the actual value is USD 43.35 M.

EPS: As of FY2025 Q3, the actual value is USD 0.12.

EBIT: As of FY2025 Q3, the actual value is USD 15.81 M.

Segment Revenue

  • Franchising Revenue: $9,929,387 for the three months ended September 30, 2025, a decrease of 36.71% from $15,688,528 for the same period in 2024.
  • Procurement Revenue: $13,406,905 for the three months ended September 30, 2025, a decrease of 23.70% from $17,571,299 for the same period in 2024.
  • Management Services Revenue: $9,462,183 for the three months ended September 30, 2025, a decrease of 21.87% from $12,110,764 for the same period in 2024.
  • Rental Services Revenue: $6,219,645 for the three months ended September 30, 2025, an increase of 50.79% from $4,124,774 for the same period in 2024.
  • Other Revenues: $4,335,115 for the three months ended September 30, 2025, an increase of 20.77% from $3,589,518 for the same period in 2024.

Operational Metrics

  • Net Income: $12,833,326 for the three months ended September 30, 2025, an increase of 352.76% from $2,834,467 for the same period in 2024.
  • Gross Profit: $30,611,487 for the three months ended September 30, 2025, a decrease of 29.20% from $43,239,090 for the same period in 2024.
  • Operating Expenses: $14,730,247 for the three months ended September 30, 2025, a decrease of 49.90% from $29,404,487 for the same period in 2024.

Cash Flow

  • Net Cash Used in Operating Activities: - $27,295,426 for the nine months ended September 30, 2025, compared to $27,886,231 provided by operating activities for the same period in 2024.
  • Net Cash Provided by Investing Activities: $3,239,523 for the nine months ended September 30, 2025, compared to - $5,554,039 used in investing activities for the same period in 2024.
  • Net Cash Provided by Financing Activities: $18,470,001 for the nine months ended September 30, 2025, compared to $11,584,038 for the same period in 2024.

Future Outlook and Strategy

  • Core Business Focus: The company plans to maintain and strengthen its market position and brand in the cosmetic medical treatment management market in Japan, Vietnam, and Singapore, and grow its presence globally.
  • Non-Core Business: The company is proceeding with the acquisition of common shares of Waqoo, Inc., a Japanese company listed on the Tokyo Stock Exchange, from the CEO of the company and other shareholders of Waqoo until the company obtains controlling interest in Waqoo.

Login to unlock1,891characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM)

SBC MEDICAL GROUP HOLDINGS INCRPRTD C/WTS 17/09/2029 (TO PUR COM)

SBCWW.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--